BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15918776)

  • 21. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
    van Burik JA; Ratanatharathorn V; Stepan DE; Miller CB; Lipton JH; Vesole DH; Bunin N; Wall DA; Hiemenz JW; Satoi Y; Lee JM; Walsh TJ;
    Clin Infect Dis; 2004 Nov; 39(10):1407-16. PubMed ID: 15546073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.
    Vehreschild JJ; Cornely OA
    Future Microbiol; 2006 Aug; 1(2):161-70. PubMed ID: 17661660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micafungin: pharmacology, experimental therapeutics and clinical applications.
    Groll AH; Stergiopoulou T; Roilides E; Walsh TJ
    Expert Opin Investig Drugs; 2005 Apr; 14(4):489-509. PubMed ID: 15882123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative evaluation of properties and clinical efficacy of the echinocandins.
    Kim R; Khachikian D; Reboli AC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micafungin for the treatment of invasive aspergillosis.
    Enoch DA; Idris SF; Aliyu SH; Micallef C; Sule O; Karas JA
    J Infect; 2014 Jun; 68(6):507-26. PubMed ID: 24480373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical review of echinocandins in pediatric patients.
    VandenBussche HL; Van Loo DA
    Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of micafungin in transplantation recipients.
    Forrest GN; Rasetto F; Akpek G; Philosophe B
    Transplantation; 2006 Dec; 82(11):1549. PubMed ID: 17164733
    [No Abstract]   [Full Text] [Related]  

  • 30. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
    Ninomiya M; Mikamo H; Tanaka K; Watanabe K; Tamaya T
    J Antimicrob Chemother; 2005 Apr; 55(4):587-90. PubMed ID: 15728144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
    Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micafungin.
    Jarvis B; Figgitt DP; Scott LJ
    Drugs; 2004; 64(9):969-82; discussion 983-4. PubMed ID: 15101786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
    Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
    J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echinocandin antifungal drugs.
    Denning DW
    Lancet; 2003 Oct; 362(9390):1142-51. PubMed ID: 14550704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients.
    Lehrnbecher T; Groll AH
    Pediatr Blood Cancer; 2010 Aug; 55(2):229-32. PubMed ID: 20583216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of micafungin in pediatric clinical trials.
    Arrieta AC; Maddison P; Groll AH
    Pediatr Infect Dis J; 2011 Jun; 30(6):e97-e102. PubMed ID: 21378595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micafungin use in children.
    Emiroglu M
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of micafungin sodium on fungal infection in critical care].
    Tateishi Y; Hirasawa H; Oda S; Nakanishi K; Kitamura S; Aikawa N
    Nihon Ishinkin Gakkai Zasshi; 2006; 47(4):293-7. PubMed ID: 17086162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.